These results fit the “low dopamine hypothesis” for explaining depressive symptoms and we suggest that the dopamine-depletion-induced down-regulation of the DAT occurs during depressive episodes in patients with AD/MD. Here, SLC6A3 is linked to Alzheimer disease.